Author:
Dijkstra Akkelies E.,Smolonska Joanna,van den Berge Maarten,Wijmenga Ciska,Zanen Pieter,Luinge Marjan A.,Platteel Mathieu,Lammers Jan-Willem,Dahlback Magnus,Tosh Kerrie,Hiemstra Pieter S.,Sterk Peter J.,Spira Avi,Vestbo Jorgen,Nordestgaard Borge G.,Benn Marianne,Nielsen Sune F.,Dahl Morten,Verschuren W. Monique,Picavet H. Susan J.,Smit Henriette A.,Owsijewitsch Michael,Kauczor Hans U.,de Koning Harry J.,Nizankowska-Mogilnicka Eva,Mejza Filip,Nastalek Pawel,van Diemen Cleo C.,Cho Michael H.,Silverman Edwin K.,Crapo James D.,Beaty Terri H.,Lomas David A.,Bakke Per,Gulsvik Amund,Bossé Yohan,Obeidat M. A.,Loth Daan W.,Lahousse Lies,Rivadeneira Fernando,Uitterlinden Andre G.,Hofman Andre,Stricker Bruno H.,Brusselle Guy G.,van Duijn Cornelia M.,Brouwer Uilke,Koppelman Gerard H.,Vonk Judith M.,Nawijn Martijn C.,Groen Harry J. M.,Timens Wim,Boezen H. Marike,Postma Dirkje S.,
Publisher
Public Library of Science (PLoS)
Reference37 articles.
1. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. american thoracic society;Am J Respir Crit Care Med,1995
2. Chronic bronchitis in the general population: Influence of age, gender and socio-economic conditions;A Ferre;Respir Med,2012
3. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary;KF Rabe;Am J Respir Crit Care Med,2007
4. Respiratory symptoms and FEV1 as predictors of hospitalization and medication in the following 12 years due to respiratory disease;J Vestbo;Eur Respir J,1989
5. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. copenhagen city heart study group;J Vestbo;Am J Respir Crit Care Med,1996